OncoHost
Precision Diagnostics and Predictive Biomarker Development
StartupOncoHost is a Binyamina-Giv'at Ada-based startup in the Health Tech & Life Sciences sector, established in 2017. Precision Diagnostics and Predictive Biomarker Development. The company has raised a total of $53.4M across 8 funding rounds, currently at the C stage. OncoHost was founded by Yuval Shaked, PhD. Key investors include OurCrowd, ALIVE Israel Healthtech Fund, Menora Mivtachim Insurance, among 7 total investors. The company has 11-50 employees. Core technologies: Biologicals, Molecules, Artificial Intelligence, Machine Learning.
With $53.4M in total funding, OncoHost is a C-stage company operating in Health Tech & Life Sciences. The company follows a B2B2C/B2B/B2C business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageC
- ProductClinical Trial
- ModelB2B2C, B2B, B2C
- Employees11-50
- HQBinyamina-Giv'at Ada
- DistrictCenter District
- Last Round$2.8M
- OurCrowd
- ALIVE Israel Healthtech FundLead
- Menora Mivtachim Insurance
7 investors total
Yuval Shaked, PhDCo-founder & Chief Scientific Advisor
43 articles covered by sources including www.prnewswire.com,
nocamels.com,
www.clinicaltrialsarena.com,
www.timesofisrael.com,
www.technologynetworks.com.
What does OncoHost do?
OncoHost is a technology company transforming the approach to precision medicine for improved patient outcomes. The company aims to understand the patient's unique response to therapy to overcome one of the major obstacles in clinical oncology today – resistance to treatment. OncoHost developed the PROphet platform. Combining bioinformatics, system biology, proteomic pattern recognition and machine learning, PROphet provides clinicians with actionable clinical insights, optimal choice of therapy, and a better understanding of their patients' personalized cancer dynamics.
How much funding has OncoHost raised?
OncoHost has raised $53.4M in total funding across 8 rounds. The company is currently at the C stage. Key investors include OurCrowd, ALIVE Israel Healthtech Fund, Menora Mivtachim Insurance.
Who founded OncoHost?
OncoHost was founded in 2017 by Yuval Shaked, PhD (Co-founder & Chief Scientific Advisor).
What sector is OncoHost in?
OncoHost operates in Health Tech & Life Sciences, Digital Healthcare, Medical Decision Support, Pharma & Medical Biotechnology, Test Diagnostics & Screening, with core technologies in Biologicals, Molecules, Artificial Intelligence, Machine Learning. Target customers: Healthcare & Life Sciences, Healthcare, Insurance Companies, Providers, Patients, Life Sciences, Pharmaceuticals.
Where is OncoHost located?
OncoHost is based in HaMelacha St 17, Binyamina-Giv'at Ada, Israel, Center District. The company also has offices abroad.